Breaking News, Promotions & Moves

Kindeva Appoints Prakash Pandian CIO to Lead Digital Transformation

Prakash brings more than 25 years of experience leading IT, data and digital functions leveraging emerging technologies to boost productivity.

By: Kristin Brooks

Managing Editor, Contract Pharma

Kindeva Drug Delivery, a global CDMO and drug delivery specialist, has appointed Prakash Pandian as Chief Information Officer to bolster its executive leadership team and support technological initiatives across the company. As Kindeva continues its digital transformation efforts, Prakash will be responsible for technology-enabled initiatives across the organization designed to drive manufacturing automation, business efficiency, and revenue growth.
 
Prakash will focus on driving automation across operations to boost manufacturing efficiencies and support Kindeva’s colleagues in adopting new technologies.  Adopting the right technologies can deliver step change in speed, efficiency and business process automation.
 
“Staying ahead in a highly competitive market means taking advantage of the latest technologies. As CIO, Prakash will create a global IT roadmap enabling us to capitalize on the best-in-class technologies and future-proof our processes. His appointment marks a pivotal point in our growth strategy as we continue to innovate and invest in the right people and technologies to deliver business value,” said Milton Boyer, CEO of Kindeva. 
 
Prakash brings more than 25 years of experience leading IT, data and digital functions by leveraging emerging technologies to boost productivity. Most recently, he served as the global CIO at Curia where he drove digital innovation and led the global IT and Global Supply Chain functions. Prior to that, he held global leadership roles at Biogen, Millipore Corporation and Merck KgAa.
 
Prakash said, “Embracing new technologies and digital capabilities will unlock further opportunities to deliver exceptional business results for Kindeva while improving efficiency and productivity. The primary goal is to ensure our investments in technologies create enterprise value, drive the business forward, and make a difference to our customers, and our patients around the world.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters